In 28 days, 4 hours, and 8 minutes (er, roughly), 1000 surgeons will convene in Paris for the International Congress for Joint Reconstruction’s first-ever World Arthroplasty Congress. Led by co-chairs Jean-Noël Argenson, M.D., Ph.D. and Jan M. K. Victor, M.D., as well as Arlen D. Hanssen, M.D. and W. Norman Scott, M.D., FACS, this event promises to bring an international perspective and the most recent insights to attendees on standard of care practices and deliver clear guidelines for current knee and hip practice.
First-Ever World Arthroplasty Congress: Experts Gather in Paris

From April 16-18, 2015 at the Palais des Congrès de Paris, world-renown arthroplasty experts will explore customized instrumentation, surgical navigation, imaging, clinical evaluations and outcomes via didactic presentations and panel discussions.
Dr. Argenson gave OTW some details: “Regarding hips, we will have an international symposium on the ideal bearing surface for total hip arthroplasty [THA] in 2015. Also on the agenda are surgical tips for solving the growing demand in revision hip surgery and an international perspective on solving the problem of instability after total hip arthroplasty.”
“Additionally, we will cover the different ways that peri-operative management of hip and knee arthroplasty is handled in Europe, the U.S., and Asia. Faculty will be reviewing long term experiences in Europe for techniques associated with ceramic on ceramic in THA, computer assisted surgery or dual mobility cups for hip instability. We will also be examining the regular use (in Europe) or total avoidance of low molecular weight heparin for DVT prophylaxis, the fast-track surgery concept for joint replacement, the use of nerve blocks or local wound injection for dealing with post-operative pain control, the rein fusion drain protocol for managing bone loss. Presenters will also report on the real values of registries around the world for following hip and knee arthroplasty.”
Professor Victor commented to OTW, “Faculty members are all key opinion leaders from the American and European knee society, as well as the thought leaders in Asia. The program has an excellent balance between proven state-of-the art technology and new techniques that appear on the horizon.”
“Some of the topics these experts will address include one stage revision of infected total knee arthroplasty, mid-term follow-up of synthetic menisci show inferior results of these ‘pre-arthroplasty’ devices, and new pathways for surgical navigation and technical aids for positioning implants.”
ICJR is an independent, membership-based 501(c)(3) non-profit organization with a mission to offer contemporary orthopaedic education, create a global orthopaedic community, and support orthopaedics and related healthcare issues through philanthropic endeavors. The predominant focus of ICJR philanthropy has and will continue to be toward resident and fellows education. Through collaborations with leading clinicians, societies, and companies in the field of orthopaedics, ICJR offers dozens of live and web-based interactive educational (continuing medical education [CME]-accredited) programs around the world each year. ICJR live meetings span the globe with meetings in Australia, China, Europe, Japan, the Middle East, Southeast Asia, South America, and the United States. Attended by thousands of orthopaedic surgeons, our live conferences feature broadcasts of live surgeries, didactic lectures, debates, poster presentations, interactive case review workshops, and cadaver/human tissue labs. Web-based educational offerings include topic-specific didactic presentations and discussions, review articles, surgical videos, as well as simulcasts from many of our live conferences.
For more information, please visit: https://icjr.net/meeting/overview.31.htm.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.